A major breakthrough in cancer study is emerging with the use of VHH fragments to re-engage mutated p53. This crucial malignant inhibitor protein is frequently lost in many kinds of malignancies, resulting uncontrolled https://madbookmarks.com/story21988764/mini-antibodies-revive-p53-new-potential-hope-for-malignant-therapy